APCETH BIOPHARMA
apceth Biopharma is a pioneer in the field of cell and gene therapy and a leading European contract development & manufacturing organization (CDMO) for complex cell-based and gene therapy products (Advanced Therapy Medicinal Products, ATMPs) located in Munich, Germany. The company was founded in 2007 and is a wholly owned subsidiary of Hitachi Chemical Co., Ltd. since April 2019. apceth Biopharma is a well-established and highly experienced GMP contract development and manufacturing organizati... on (CDMO). The broad experience gained through pharmaceutical development and GMP production of their own innovative cell therapeutics, combined with the GMP infrastructure, form a firm basis for their successful CDMO activities. apceth Biopharma offers comprehensive contract GMP services for clinical and commercial stage Advanced Therapy Medicinal Products (ATMPs). This includes product and process development and associated GMP services for all types of complex cell and gene therapeutics. apceth Biopharma owns and operates two state-of-the-art GMP/BSL2 production facilities in Ottobrunn near Munich and in Munich / Großhadern (Germany). The facilities comprise 600 m2 of cleanroom area. Their GMP manufacturing process and facilities have been certified since 2010. They are fully compliant with all current EU regulations (ATMP regulation (EC) No.1394/2007) and ICH guidelines.
APCETH BIOPHARMA
Social Links:
Industry:
Biotechnology Genetics Manufacturing
Founded:
2007-01-01
Address:
Munich, Bayern, Germany
Country:
Germany
Website Url:
http://www.apceth.com
Total Employee:
11+
Status:
Active
Contact:
+4908970096080
Email Addresses:
[email protected]
Total Funding:
6.35 M USD
Technology used in webpage:
SPF Google Tag Manager Content Delivery Network Domain Not Resolving Global Site Tag Mobile Non Scaleable Content Microsoft Exchange Online Amazon Office 365 Mail IPv6
Similar Organizations
Frontida Biopharm
Frontida Biopharm, Inc., an affiliate of Frontage Laboratories, Inc., is a Contract Development and Manufacturing Organization.
Voyager Therapeutics
Voyager Therapeutics is a gene therapy company developing treatments for fatal and debilitating diseases of the central nervous system
Current Employees Featured
Investors List
BioM Venture Capital
BioM Venture Capital investment in Series B - apceth Biopharma
ATHOS Service
ATHOS Service investment in Series A - apceth Biopharma
More informations about "apceth Biopharma" on Search Engine
apceth Biopharma - Crunchbase Company Profile & Funding
Phone Number +4908970096080. apceth Biopharma is a pioneer in the field of cell and gene therapy and a leading European contract development & manufacturing organization (CDMO) for complex cell-based and gene therapy products (Advanced Therapy Medicinal Products, ATMPs) located in Munich, Germany.See details»
About Minaris Regenerative Medicine
Minaris Regenerative Medicine GmbH based in Munich, Germany, formerly named apceth Biopharma GmbH and founded in 2007. Asia Minaris Regenerative Medicine Co., Ltd. based in Yokohama, formerly named Showa Denko Materials Co., Ltd. , and founded as Hitachi Chemical Co., Ltd. in 2018.See details»
Minaris Regenerative Medicine GmbH | LinkedIn
Apceth Biopharma has adopted the new name Minaris Regenerative Medicine Minaris Regenerative Medicine is a global contract development and manufacturing organization (CDMO) for cell and gene...See details»
apceth Biopharma Company Profile - Office Locations ... - Craft
Apceth Biopharma is a contract development and manufacturing organization focused on cell and gene therapy. The company provides product and process development as well as associated GMP services for complex cell and gene therapeutics. It serves pharmaceutical and biotechnology companies.See details»
Hitachi Chemical Co. Ltd. Completes Acquisition of apceth Biopharma ...
Apceth Biopharma manufactures cell and gene therapy products for American and European clients through two manufacturing sites in Munich, Germany, both certified for GMP manufacturing since 2010. These facilities are fully compliant with all current EU regulations (ATMP regulation (EC) No.1394/2007) and ICH guidelines.See details»
apceth Biopharma Company Profile 2024: Valuation, Investors ...
Apceth Biopharma Overview. Update this profile. Year Founded. 2007. Status. Acquired/ Merged. Employees. 155. Latest Deal Type. M&A. Financing Rounds. 3. General Information. Description. Developer of stem cell-based therapies intended for the treatment of malignant and non-malignant diseases.See details»
bluebird bio and apceth Biopharma Establish Commercial Drug …
Apceth Biopharma is a pioneering biopharmaceutical company with a pipeline of cell-based gene therapeutics for the treatment of major chronic diseases (chronic lung disease, metabolic and autoimmune diseases) and solid cancer.See details»
apceth to Manufacture First Potential One-Time Gene Therapy for ...
About apceth Biopharma GmbH. apceth Biopharma is a pioneering company in cell therapies and regenerative medicine with an innovative portfolio of drug candidates for the treatment of inflammation, autoimmunity and solid tumors. apceth is developing two proprietary next generation gene therapy products, which are based on the introduction …See details»
apceth Biopharma - Funding, Financials, Valuation & Investors
Apceth Biopharma has raised a total of. €4.7M. in funding over 2 rounds. Their latest funding was raised on Feb 4, 2013 from a Series B round. apceth Biopharma is funded by BioM Venture Capital. Unlock for free.See details»
Hitachi Chemical Co. Ltd. to Acquire apceth Biopharma GmbH, …
Jan 31, 2019 ALLENDALE, N.J.-- ( BUSINESS WIRE )--Hitachi Chemical Advanced Therapeutics Solutions, LLC announces an agreement by which apceth Biopharma GmbH (“apceth Biopharma”), a contract...See details»
Hitachi Chemical Co. Ltd. to Acquire apceth Biopharma GmbH
Jan 31, 2019 apceth Biopharma is a pioneering company in regenerative medicines and a leading and certified Contract Development and Manufacturing Organization for cell and gene therapeutics with a broad international customer base. apceth owns state-of-the-art manufacturing facilities with Grade B/A, C and D cleanrooms (ISO 5, ISO 7, ISO 8, …See details»
Hitachi Chemical to Acquire apceth Biopharma
On Jan. 31, 2019, apceth Biopharma, a contract development and manufacturing organization (CDMO) in the field of cell and gene therapy, announced today that Hitachi Chemical will enter into an agreement to acquire all shares of apceth Biopharma. The acquisition is expected to close in April 2019.See details»
Hitachi Chemical Co. Ltd. to Acquire apceth Biopharma GmbH
Apceth Biopharma GmbH, a leading contract manufacturing organization in the field of cell and gene therapy, announces today that Hitachi Chemical Co., Ltd. will enter into an agreement to acquire all shares of apceth Biopharma GmbH. This acquisition is expected to close in April 2019.See details»
Hitachi Chemical To Acquire Cell- and Gene-Therapy CDMO Apceth Biopharma
Feb 1, 2019 Hitachi Chemical, a Tokyo-based chemicals and industrial manufacturer, has agreed to acquire Apceth Biopharma, a Munich, Germany-based contract development and manufacturing organization (CDMO) of cell …See details»
Hitachi Chemical acquires apceth Biopharma - Crunchbase
Jan 31, 2019 Overview. Acquired Organization: apceth Biopharma apceth Biopharma is a GMP contract development and manufacturing organization. Acquiring Organization: Hitachi Chemical Hitachi Chemical co., ltd. is a chemical manufacturer engaged in multiple industries. Announced Date Jan 31, 2019. Acquisition Type Acquisition. Acquisition …See details»
DCPrime and apceth Biopharma GmbH announce manufacturing …
Leiden, The Netherlands, and Munich, Germany – DCPrime BV, a clinical stage company developing dendritic cell vaccines to treat cancer, and apceth Biopharma GmbH, an established contract manufacturing organization in the field of gene and cell therapy, report today that they have entered into a strategic manufacturing agreement.See details»
apceth | VentureRadar
"apceth Biopharma is a pioneer in the field of cell and gene therapy and a leading European contract development and manufacturing organization (CDMO) for complex cell-based and gene therapy products (Advanced Therapy Medicinal Products, ATMPs) located in Munich, Germany.See details»
apceth Biopharma GmbH Manufactures DCprime’s Cell-Based
Munich, Germany, November 16, 2018 - apceth Biopharma GmbH, an established contract manufacturing organization in the field of gene and cell therapy, has started supplying clinical batches of DCprime’s cell-based cancer vaccine DCP-001 to a phase II clinical study for the treatment of Acute Myeloid Leukemia (AML).See details»
Hitachi Chemical Co. Ltd. to Acquire apceth Biopharma GmbH
MUNICH, Germany, January 31, 2019 / — apceth Biopharma GmbH, a leading contract manufacturing organization in the field of cell and gene therapy, announces today that Hitachi Chemical Co., Ltd. will enter into an agreement to acquire all shares of apceth Biopharma GmbH. This acquisition is expected to close in April 2019.See details»
apceth Starts Commercial Manufacturing of Zynteglo, bluebird …
Apceth Biopharma, a subsidiary of Hitachi Chemical Co., Ltd., is a pioneering company in regenerative medicines and a leading and certified Contract Development and Manufacturing Organization for cell and gene therapeutics with a broad international customer base. apceth owns state-of-the-art manufacturing facilities with Grade B/A, C …See details»